The Role of AMPK/mTOR Modulators in the Therapy of Acute Myeloid Leukemia (CROSBI ID 252374)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Višnjić, Dora ; Dembitz, Vilma ; Lalić, Hrvoje
engleski
The Role of AMPK/mTOR Modulators in the Therapy of Acute Myeloid Leukemia
Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid represents the most successful pharmacological therapy of acute myeloid leukemia (AML). Numerous studies demonstrate that drugs that inhibit mechanistic target of rapamycin (mTOR) and activate AMP-kinase (AMPK) have beneficial effects in promoting differentiation and blocking proliferation of AML. Most of these drugs are already in use for other purposes ; rapalogs as immunosuppressants, biguanides as oral antidiabetics, and 5-amino-4- imidazolecarboxamide ribonucleoside (AICAr, acadesine) as an exercise mimetic. Although most of these pharmacological modulators have been widely used for decades, their mechanism of action is only partially understood. In this review, we summarize the role of AMPK and mTOR in hematological malignancies and discuss the possible role of pharmacological modulators in proliferation and differentiation of leukemia cells.
AML ; AMPK ; mTOR ; rapamycin ; metformin ; AICAR ; differentiation
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
26 (12)
2019.
2208-2229
objavljeno
0929-8673
1875-533X
10.2174/0929867325666180117105522
Povezanost rada
Temeljne medicinske znanosti